February 11 not only marks a pivotal moment in South African history with Nelson Mandela's release but also celebrates a groundbreaking medical achievement as Cape Town performs its first Genicular ...

Onyx is a liquid embolic agent that is injected into an artery to occlude blood flow. In subdural hematoma, it is used to block the MMA, stopping the chronic oozing of blood into the subdural space.

According to SNS Insider Research, Uterine Fibroid Market Growth is Driven by Rising Prevalence, Technological Advances in Minimally Invasive Procedures, and Healthcare Infrastructure Expansion.Austin ...

The 2026 International Stroke Conference (ISC), held February 4-6 in New Orleans, Louisiana, delivered potentially ...

Chronic subdural hematomas are a common type of intracranial hematoma in older adults. They are a significant source of morbidity and mortality, with an incidence that is increasing due to population ...

Chronic subdural hematomas account for over 90,000 hospitalizations annually and are projected to become the most common neurosurgical condition by 2030. Current interventions--including surgery and ...

Philips (NYSE: PHG) announced today that the Seismic research consortium received nearly $28 million (€23.5 million) in ...

The middle meningeal artery (MMA) has emerged as a potential therapeutic target for severe, treatment-resistant headache syndromes. Growing evidence suggests that the MMA and its dural branches are ...

Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation ...

Royal Philips, together with Erasmus MC and a broad consortium of industry, academic, and patient partners, has secured funding from the EU’s Innovative Health Initiative to coordinate the five-year ...

Milestone marks the commercial use of the first and only liquid embolic approved for hypervascular tumor embolization supported by a prospective, randomized, controlled clinical trial BEDFORD, Mass., ...

Coronary artery disease — or CAD — is a heart disease that’s often treated with medications as well as lifestyle and dietary changes. If your condition worsens, your doctor might suggest percutaneous ...